These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 22235372)
1. Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy. Mizoguchi H; Yamada K; Nabeshima T Biochem Res Int; 2011; 2011():681385. PubMed ID: 22235372 [TBL] [Abstract][Full Text] [Related]
2. Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures. Mizoguchi H; Yamada K Clin Psychopharmacol Neurosci; 2013 Aug; 11(2):45-52. PubMed ID: 24023547 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632 [TBL] [Abstract][Full Text] [Related]
4. An alternate perspective on the roles of TIMPs and MMPs in pathology. Moore CS; Crocker SJ Am J Pathol; 2012 Jan; 180(1):12-6. PubMed ID: 22033229 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Kim YS; Joh TH Biomol Ther (Seoul); 2012 Mar; 20(2):133-43. PubMed ID: 24116286 [TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. Ethell IM; Ethell DW J Neurosci Res; 2007 Oct; 85(13):2813-23. PubMed ID: 17387691 [TBL] [Abstract][Full Text] [Related]
8. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system]. Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628 [TBL] [Abstract][Full Text] [Related]
9. Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease. Naphade S; Embusch A; Madushani KL; Ring KL; Ellerby LM Front Neurosci; 2017; 11():736. PubMed ID: 29459817 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy. Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851 [TBL] [Abstract][Full Text] [Related]
12. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis]. Fink K; Boratyński J Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203 [TBL] [Abstract][Full Text] [Related]
13. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. Mroczko B; Groblewska M; Barcikowska M J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694 [TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. Liu J; Khalil RA Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828 [TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinases in the Hematopoietic Microenvironment. Janowska-Wieczorek A; Matsuzaki A; Marquez LA Hematology; 1999; 4(6):515-27. PubMed ID: 27420748 [TBL] [Abstract][Full Text] [Related]
16. Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer. Kaczorowska A; Miękus N; Stefanowicz J; Adamkiewicz-Drożyńska E Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751899 [TBL] [Abstract][Full Text] [Related]
17. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Reynolds JJ Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940 [TBL] [Abstract][Full Text] [Related]
18. Implication of matrix metalloproteinases in regulating neuronal disorder. Mukherjee A; Swarnakar S Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Raffetto JD; Khalil RA Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629 [TBL] [Abstract][Full Text] [Related]
20. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor. Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]